Europe - Euronext Amsterdam - AMS:PHIA - NL0000009538 - Common Stock
The current stock price of PHIA.AS is 24.45 EUR. In the past month the price increased by 7.61%. In the past year, price decreased by -3.4%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 17.18 | 105.51B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 19.29 | 52.00B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.03 | 22.85B | ||
| BIM.PA | BIOMERIEUX | 29.74 | 13.59B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 146.7 | 4.41B | ||
| DIA.MI | DIASORIN SPA | 21.82 | 4.04B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 26.3 | 3.79B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 11.16 | 1.35B | ||
| ELN.MI | EL.EN. SPA | 22.44 | 1.15B | ||
| DRW8.DE | DRAEGERWERK AG | 9.02 | 1.09B | ||
| EUZ.DE | ECKERT & ZIEGLER SE | 24.18 | 998.53M | ||
| GVS.MI | GVS SPA | 45.22 | 769.96M |
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. The company is headquartered in Eindhoven, Noord-Brabant and currently employs 67,035 full-time employees. The company went IPO on 2009-09-18. The firm's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
KONINKLIJKE PHILIPS NV
High Tech Campus 5
Eindhoven NOORD-BRABANT NL
Employees: 66678
Phone: 31205977777
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. The company is headquartered in Eindhoven, Noord-Brabant and currently employs 67,035 full-time employees. The company went IPO on 2009-09-18. The firm's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
The current stock price of PHIA.AS is 24.45 EUR. The price increased by 2.86% in the last trading session.
PHIA.AS does not pay a dividend.
PHIA.AS has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
PHIA.AS stock is listed on the Euronext Amsterdam exchange.
The Revenue of KONINKLIJKE PHILIPS NV (PHIA.AS) is expected to decline by -2.27% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
KONINKLIJKE PHILIPS NV (PHIA.AS) has a market capitalization of 23.54B EUR. This makes PHIA.AS a Large Cap stock.
ChartMill assigns a technical rating of 3 / 10 to PHIA.AS. When comparing the yearly performance of all stocks, PHIA.AS is a bad performer in the overall market: 70.02% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to PHIA.AS. PHIA.AS has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months PHIA.AS reported a non-GAAP Earnings per Share(EPS) of 1.48. The EPS increased by 15.15% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.91% | ||
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| Debt/Equity | 0.69 |
27 analysts have analysed PHIA.AS and the average price target is 27.59 EUR. This implies a price increase of 12.82% is expected in the next year compared to the current price of 24.45.
For the next year, analysts expect an EPS growth of 4.35% and a revenue growth -2.27% for PHIA.AS